UBS AM’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-3,556
| Closed | -$120K | – | 2889 |
|
|
2019
Q1 | $120K | Buy |
+3,556
| New | +$120K | ﹤0.01% | 2552 |
|
|
2018
Q4 | – | Sell |
-2,490
| Closed | -$153K | – | 2837 |
|
|
2018
Q3 | $153K | Hold |
2,490
| – | – | ﹤0.01% | 2494 |
|
|
2018
Q2 | $184K | Buy |
2,490
+170
| +7% | +$12.5K | ﹤0.01% | 2495 |
|
|
2018
Q1 | $152K | Buy |
+2,320
| New | +$152K | ﹤0.01% | 2425 |
|
|
2016
Q4 | – | Sell |
-1,050
| Closed | -$209K | – | 2712 |
|
|
2016
Q3 | $209K | Hold |
1,050
| – | – | ﹤0.01% | 2446 |
|
|
2016
Q2 | $136K | Hold |
1,050
| – | – | ﹤0.01% | 2546 |
|
|
2016
Q1 | $98K | Buy |
+1,050
| New | +$98K | ﹤0.01% | 2570 |
|
|
2015
Q2 | – | Sell |
-8,970
| Closed | -$2.08M | – | 2733 |
|
|
2015
Q1 | $2.08M | Sell |
8,970
-100
| -1% | -$23.2K | ﹤0.01% | 1344 |
|
|
2014
Q4 | $2.09M | Buy |
+9,070
| New | +$2.09M | ﹤0.01% | 1308 |
|